sameAs
Mandatory disclosure of pharmaceutical industry-funded events for health professionalsFactors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than othersMeasuring the effectiveness of scientific gatekeepingRegulatory agencies hold the key to improving Cochrane reviews of drugsA Clearer View of Evidence in Treating Macular Degeneration: Off-Label Policies and Independent ResearchCommunity pharmacy interventions for health promotion: effects on professional practice and health outcomesHealthcare outcomes assessed with observational study designs compared with those assessed in randomized trialsThe effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countriesWhy the Cochrane Risk of Bias Tool Should Include Funding Source as a Standard ItemIndustry sponsorship and research outcomeAssociation between personal conflicts of interest and recommendations on medical interventionsInterventions for tobacco use cessation in people in treatment for or recovery from substance abuseMeasuring the Performance of the Cochrane LibraryHealthcare outcomes assessed with non-experimental designs compared with those assessed in randomised trialsEffect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patternsIndustry sponsorship and research outcomeThe cochrane library oversight committeeMaking systematic reviews globalAssociation of trial registration with the results and conclusions of published trials of new oncology drugsThe cycle of bias in health research: a framework and toolbox for critical appraisal trainingPublic health under attack: the American Stop Smoking Intervention Study (ASSIST) and the tobacco industryTobacco use among individuals with schizophrenia: what role has the tobacco industry played?Pharmaceutical industry sponsorship and research outcome and quality: systematic reviewTobacco industry denormalisation as a tobacco control intervention: a reviewOutcome reporting in industry-sponsored trials of gabapentin for off-label useA proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicalsApplication of the Navigation Guide systematic review methodology to the evidence for developmental and reproductive toxicity of triclosanCharacteristics and impact of drug detailing for gabapentinReporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentationCorrection: Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and PresentationFactors associated with results and conclusions of trials of thiazolidinedionesPriority medicines for maternal and child health: a global survey of national essential medicines listsNonindustry-sponsored preclinical studies on statins yield greater efficacy estimates than industry-sponsored studies: a meta-analysisStrategies for obtaining unpublished drug trial data: a qualitative interview studyExpanding disease definitions in guidelines and expert panel ties to industry: a cross-sectional study of common conditions in the United StatesRealist review of policy intervention studies aimed at reducing exposures to environmental hazards in the United StatesWhy Having a (Nonfinancial) Interest Is Not a Conflict of InterestImplementation of a workplace smoking ban in bars: the limits of local discretion.Searching for unpublished data for Cochrane reviews: cross sectional study.Tobacco industry research and protection of human subjects: a case study of R. J. Reynolds.
P50
Q21092357-8A0847EA-E143-4EA3-BEEB-C0EC6885F5F1Q21563421-CAAEA804-D32E-4DDB-B529-B6B788EF2066Q21686060-112C1BA6-F233-46CD-B734-7BF92C81ECF3Q21686060-601A53CB-6350-4D16-9250-A2AF86AE899BQ21686060-f41dee76-43e2-ebbe-ea8b-50389fd95ee4Q24186305-DD26BA92-F79B-45E1-B082-01D916976F9CQ24193409-39BECBF1-341E-48E2-93DB-9DC4AC624BE2Q24194987-750C2EE6-DA38-4DC4-938A-E1B9EDB41525Q24197533-94AEB41A-F452-4195-AC60-4EA2732CD98FQ24200923-5843B58C-C31C-4C3D-8647-C863BD256E26Q24201550-67DCB86C-5CCA-4331-A6C0-8AE9109376BBQ24202591-668D32C7-FB80-489E-9327-D6587A7162C3Q24202627-D09CE414-4A28-4CE2-AE61-BF757AD54080Q24202711-F5BECF04-0415-413C-84C3-830AD13E062AQ24202776-5DBAC708-B3A9-423D-8BF9-DDA2F6041CBBQ24203827-EF3EF80D-D5A2-4C8D-8656-85C44DEBFD6AQ24234308-BA874309-AA4C-4AD6-A24F-7B135EC56981Q24234843-CCDE9ACB-FF70-4F82-B757-0F7704AC33F4Q24236505-DD972132-804E-4CFD-8950-D7FD021159F7Q24236518-779EAAE2-9BEC-48EC-B9F4-E49E515D1DA1Q24288921-3ECCF341-CD58-42B0-8195-B6F2BEEFCFECQ24289237-F2C331AD-B001-4B73-9824-522BF5582665Q24544452-704F348E-B28E-4456-A601-49C1D2F8CD70Q24643892-270A2F0A-473F-4EF2-B08C-53B35CB032D7Q24673248-1C51BBF8-A1FD-4D5A-B14A-FE58CABAA47AQ27000988-D435B82B-32E0-4291-9E46-66724BBFAB90Q28264491-2FEFF1F5-69DF-4A09-9B3E-5130597CA3CFQ28384100-227E2A83-5D6D-46B5-A7C4-F3ABF6B2059CQ28384535-EBA7F015-A2AB-4446-8742-0AF2C6AE71B0Q28469192-0BA481D1-3A6A-44F8-9FEB-37CF826E60B9Q28474127-BD77679E-3CDA-4E28-ABAE-90052808F261Q28474668-ACE60906-7748-432E-9513-85494022D434Q28475588-F3655CFE-E549-463F-9E05-3100050D3855Q28484030-32DCF486-8B90-402D-B063-A3D5CEEBD30BQ28538894-8864155B-39B7-4CF8-9E70-B243DF5646F2Q28681320-8EDCF7F4-0654-49F8-B8D4-9970068A4625Q28682030-190149BB-AAC8-477A-AD54-0A87B6D9A016Q28829660-15C25D8F-859A-49B5-B494-11388DA8CDB2Q30224333-49AEFCB3-9BDC-46E1-8FE9-64117B4C50A9Q30485697-D370CDA0-2469-4943-A266-889741BE1C15
P50
description
American scientist
@en
Amerikaans onderzoekster
@nl
científica estadounidense
@es
eolaí Meiriceánach
@ga
nolavan Lamerikänik
@vo
scientifique américaine
@fr
siensiste american
@lfn
usona sciencisto
@eo
name
Lisa Bero
@ast
Lisa Bero
@de
Lisa Bero
@en
Lisa Bero
@es
Lisa Bero
@fr
Lisa Bero
@ga
Lisa Bero
@it
Lisa Bero
@nl
Lisa Bero
@sl
لیزا برو
@azb
type
label
Lisa Bero
@ast
Lisa Bero
@de
Lisa Bero
@en
Lisa Bero
@es
Lisa Bero
@fr
Lisa Bero
@ga
Lisa Bero
@it
Lisa Bero
@nl
Lisa Bero
@sl
لیزا برو
@azb
altLabel
Lisa A Bero
@en
Lisa A. Bero
@en
prefLabel
Lisa Bero
@ast
Lisa Bero
@de
Lisa Bero
@en
Lisa Bero
@es
Lisa Bero
@fr
Lisa Bero
@ga
Lisa Bero
@it
Lisa Bero
@nl
Lisa Bero
@sl
لیزا برو
@azb
P106
P1153
7006671378
P19
P21
P31
P496
0000-0003-1893-6651
P551
P569
1958-08-04T00:00:00Z